Health
Bedside trial of COVID-19 ICU patients sees hydrocortisone improve recovery – Mirage News
Researchers have found that intravenous hydrocortisone improves recovery and survival for critically ill COVID-19 patients. The finding comes as a result…
- Researchers have found that intravenous hydrocortisone improves recovery and survival for critically ill COVID-19 patients.
- The finding comes as a result of the REMAP-CAP trial that was set up by a group of intensive care specialists from around the world to future-proof for pandemics like COVID-19.
- COVID-19 patients from more than 200 intensive care units around the world have been part of this adaptive randomised trial.
A global study, led from Mo…
Click here to view the original article.
Continue Reading
-
Noosa News10 hours agoPill checking to resume in Queensland months after government axed funding
-
Noosa News20 hours agoBrisbane nation’s third-youngest capital; Leaders condemn anti-immigration rally
-
General23 hours agoAs Iran-Australia relations plunge to a new low, Tehran faces another diplomatic setback
-
Business12 hours agoBrokers name 3 ASX shares to buy today 29 August 2025